囊性纤维化的临床进展
Clinical Advances in Cystic Fibrosis.
作者信息
Imperlini Esther, Papa Rosanna
机构信息
Department for Innovation in Biological, Agro-Food and Forest Systems, University of Tuscia, 01100 Viterbo, Italy.
Department of Public Health and Infectious Diseases, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy.
出版信息
J Clin Med. 2022 Oct 26;11(21):6306. doi: 10.3390/jcm11216306.
Abstract
Over recent decades, significant advances have been achieved in ameliorating clinical outcomes for patients with cystic fibrosis (CF) [...].
摘要
在最近几十年里，囊性纤维化（CF）患者的临床治疗效果得到了显著改善[……]。
相似文献
1
Clinical Advances in Cystic Fibrosis.
J Clin Med. 2022 Oct 26;11(21):6306. doi: 10.3390/jcm11216306.
2
Liver disease in cystic fibrosis.
Paediatr Respir Rev. 2014 Mar;15(1):69-74. doi: 10.1016/j.prrv.2013.05.001. Epub 2013 Jun 14.
3
Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis.
Eur J Med Chem. 2021 Jan 1;209:112921. doi: 10.1016/j.ejmech.2020.112921. Epub 2020 Oct 9.
4
CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Gene. 2014 May 1;540(2):183-90. doi: 10.1016/j.gene.2014.02.040. Epub 2014 Feb 26.
5
Research advances in molecular mechanisms underlying the pathogenesis of cystic fibrosis: From technical improvement to clinical applications (Review).
Mol Med Rep. 2020 Dec;22(6):4992-5002. doi: 10.3892/mmr.2020.11607. Epub 2020 Oct 16.
6
Cystic fibrosis: an overview.
J Clin Gastroenterol. 2005 Apr;39(4):307-17. doi: 10.1097/01.mcg.0000155140.63510.cd.
7
Pharmacogenetics of cystic fibrosis treatment.
Pharmacogenomics. 2016 Aug;17(13):1453-63. doi: 10.2217/pgs.16.25. Epub 2016 Aug 4.
8
Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy.
Pediatr Pulmonol. 2022 Feb;57 Suppl 1:S60-S74. doi: 10.1002/ppul.25660. Epub 2021 Sep 9.
9
[Italian Cystic Fibrosis Registry. Report 2011-2014].
Epidemiol Prev. 2018 Jan-Feb;42(1S1):1-32. doi: 10.19191/EP18.1-S1.P001.001.
10
Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.
Pharmacol Ther. 2010 Feb;125(2):219-29. doi: 10.1016/j.pharmthera.2009.10.006. Epub 2009 Nov 10.
引用本文的文献
1
Uncomplicated SARS-CoV-2 Infections with Preserved Lung Function in Pediatric Patients with Cystic Fibrosis: A Three-Year Single-Centre Experience.
J Clin Med. 2025 Apr 25;14(9):2979. doi: 10.3390/jcm14092979.
2
Therapeutic Interventions for Infections in Cystic Fibrosis Patients: A Review of Phase IV Trials.
J Clin Med. 2024 Oct 30;13(21):6530. doi: 10.3390/jcm13216530.
3
Virulence of in Cystic Fibrosis: Relationships between Normoxia and Anoxia Lifestyle.
Antibiotics (Basel). 2023 Dec 19;13(1):1. doi: 10.3390/antibiotics13010001.
本文引用的文献
1
Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis.
J Pers Med. 2022 Aug 16;12(8):1321. doi: 10.3390/jpm12081321.
2
: Recent Advances in Vaccine Development.
Vaccines (Basel). 2022 Jul 8;10(7):1100. doi: 10.3390/vaccines10071100.
3
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.
Signal Transduct Target Ther. 2022 Jun 25;7(1):199. doi: 10.1038/s41392-022-01056-1.
4
CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France.
Cells. 2022 May 28;11(11):1769. doi: 10.3390/cells11111769.
5
Cystic fibrosis year in review 2021.
Pediatr Pulmonol. 2022 Jul;57(7):1590-1599. doi: 10.1002/ppul.25948. Epub 2022 May 27.
6
Cystic fibrosis.
Lancet. 2021 Jun 5;397(10290):2195-2211. doi: 10.1016/S0140-6736(20)32542-3.
7
: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors.
Int J Mol Sci. 2021 Mar 18;22(6):3128. doi: 10.3390/ijms22063128.
8
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.
Nat Rev Microbiol. 2021 May;19(5):331-342. doi: 10.1038/s41579-020-00477-5. Epub 2020 Nov 19.
9
Essential oils against bacterial isolates from cystic fibrosis patients by means of antimicrobial and unsupervised machine learning approaches.
Sci Rep. 2020 Feb 14;10(1):2653. doi: 10.1038/s41598-020-59553-8.
10
Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.
Am J Respir Crit Care Med. 2020 May 15;201(10):1193-1208. doi: 10.1164/rccm.201910-1943SO.
Zotero 插件